Pathological upgrading in prostate cancer treated with surgery in the United Kingdom: trends and risk factors from the British Association of Urological Surgeons Radical Prostatectomy Registry

被引：0
|
作者：
Nicholas Bullock
Andrew Simpkin
Sarah Fowler
Murali Varma
Howard Kynaston
Krishna Narahari
机构：
[1] Cardiff University School of Medicine,Division of Cancer and Genetics
[2] University Hospital of Wales,Department of Urology, Cardiff and Vale University Health Board
[3] National University of Ireland,School of Mathematics, Statistics and Applied Mathematics
[4] British Association of Urological Surgeons,Department of Cellular Pathology, Cardiff and Vale University Health Board
[5] University Hospital of Wales,undefined
来源：
BMC Urology | / 19卷
关键词：
Gleason grade; Needle biopsy; Pathological; Prostate cancer; Radical prostatectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] MORTALITY RISK FACTORS IN EUROPEAN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY. COMPETING RISK ANALYSIS WITH 15-YEARS FOLLOW UP
    Boehm, Katharina
    Beyer, Burkhard
    Larcher, Alessandro
    Schiffmann, Jonas
    Karakiewicz, Pierre
    Salomon, Georg
    Huland, Hartwig
    JOURNAL OF UROLOGY, 2015, 193 (04): : E656 - E656
  • [42] Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
    Epstein, Jonathan I.
    Feng, Zhaoyong
    Trock, Bruce J.
    Pierorazio, Phillip M.
    EUROPEAN UROLOGY, 2012, 61 (05) : 1019 - 1024
  • [43] The prognostic value of 18F-PSMA-1007 PET/CT in predicting pathological upgrading of newly diagnosed prostate cancer from systematic biopsy to radical prostatectomy
    Zheng, Anqi
    Wang, Zhuonan
    Luo, Liang
    Chang, Ruxi
    Gao, Jungang
    Wang, Bo
    Duan, Xiaoyi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Upgrading risk in prostate cancer after combined prostate biopsy according to the site of positive cores: Results in 658 patients treated with robot-assisted radical prostatectomy in tertiary referral centers
    Bianchi, A.
    Califano, G.
    Morra, S.
    Gallina, S.
    Colla Ruvolo, C.
    Ornaghi, P., I
    Di Bello, F.
    Ditonno, F.
    Montanaro, F.
    Cerruto, M. A.
    Imbimbo, C.
    Antonelli, A.
    Longo, N.
    EUROPEAN UROLOGY, 2024, 85 : S1091 - S1091
  • [45] Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy
    Bradbury, Melissa
    Founta, Christina
    Taylor, Wendy
    Kucukmetin, Ali
    Naik, Raj
    Ang, Christine
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1476 - 1483
  • [46] Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: Can nerve-sparing surgery increase the risk?
    Roder, Martin Andreas
    Thomsen, Frederik Birkebaek
    Christensen, Ib Jarle
    Toft, Birgitte Gronkaer
    Brasso, Klaus
    Vainer, Ben
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (01) : 15 - 20
  • [47] Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
    Murray, Nigel P.
    Aedo, Socrates
    Fuentealba, Cynthia
    Reyes, Eduardo
    Salazar, Anibal
    Antonio Lopez, Marco
    Minzer, Simona
    Orrego, Shenda
    Guzman, Eghon
    ECANCERMEDICALSCIENCE, 2019, 13
  • [48] The association of PTEN loss on outcome in patients with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP).
    Keizman, D.
    Zhang, Z.
    Sinibaldi, V. J.
    DeMarzo, A.
    Gurel, B.
    Lotan, T.
    Hicks, J.
    Rosenbaum, E.
    Antonarakis, E. S.
    Kim, J. J.
    Carducci, M. A.
    Eisenberger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
    Porcaro, Antonio Benito
    Bianchi, Alberto
    Panunzio, Andrea
    Gallina, Sebastian
    Serafin, Emanuele
    Tafuri, Alessandro
    Trabacchin, Nicolo
    Orlando, Rossella
    Ornaghi, Paola Irene
    Mazzucato, Giovanni
    Vidiri, Stefano
    D'Aietti, Damiano
    Montanaro, Francesca
    Brusa, Davide
    Patuzzo, Giulia Marafioti
    Artoni, Francesco
    Baielli, Alberto
    Migliorini, Filippo
    De Marco, Vincenzo
    Veccia, Alessandro
    Brunelli, Matteo
    Siracusano, Salvatore
    Cerruto, Maria Angela
    Antonelli, Alessandro
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (08) : 2597 - 2605
  • [50] THE TMPRSS2-ERG GENE FUSION STATUS IN PROSTATE CANCER PATIENTS TREATED BY RADICAL PROSTATECTOMY DEFINES A DIFFERENT PROGNOSTIC PANEL OF CLINICO-PATHOLOGICAL FACTORS
    Rubio-Briones, J.
    Fernandez-Serra, A.
    Calatrava, A.
    Rubio, L.
    Bonillo, M. A.
    Garcia-Casado, Z.
    Iborra, I.
    Solsona, E.
    Lopez-Guerrero, J. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 220 - 221
12345